Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP3610340B2 - Functional food for suppressing blood sugar or blood pressure rise - Google Patents
[go: Go Back, main page]

JP3610340B2 - Functional food for suppressing blood sugar or blood pressure rise - Google Patents

Functional food for suppressing blood sugar or blood pressure rise Download PDF

Info

Publication number
JP3610340B2
JP3610340B2 JP2002000077A JP2002000077A JP3610340B2 JP 3610340 B2 JP3610340 B2 JP 3610340B2 JP 2002000077 A JP2002000077 A JP 2002000077A JP 2002000077 A JP2002000077 A JP 2002000077A JP 3610340 B2 JP3610340 B2 JP 3610340B2
Authority
JP
Japan
Prior art keywords
citrus
suppressing
name
functional food
blood pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002000077A
Other languages
Japanese (ja)
Other versions
JP2003199527A (en
Inventor
和枝 田口
茂 田口
Original Assignee
有限会社カンズ研究開発
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 有限会社カンズ研究開発 filed Critical 有限会社カンズ研究開発
Priority to JP2002000077A priority Critical patent/JP3610340B2/en
Publication of JP2003199527A publication Critical patent/JP2003199527A/en
Application granted granted Critical
Publication of JP3610340B2 publication Critical patent/JP3610340B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、血糖または血圧の上昇を抑制するための機能性食品に関するものである。
【0002】
【従来の技術】
今日、欧米先進国を中心として糖尿病や高血圧症などの生活習慣病が蔓延しつつあり、日本国も例外ではなく、食環境の欧米化に伴う生活習慣病の急増が顕在化している。その結果、悪性腫瘍、および脳や心臓の循環器障害が死亡原因となる例が近年増加傾向にある。
【0003】
【発明が解決しようとする課題】
しかるに、従来の糖尿病や高血圧症の治療効果の高い医療用医薬品は、一般的に副作用が強い上に多剤服用による重複毒性の問題などが存在するため、長期間に亘る使用には適していない。
【0004】
本発明は、このような従来の問題点を解消すべく案出されたものであり、その主な目的は、生活習慣病の中核を占める糖尿病または高血圧症の進行を安全に抑制することのできる機能性食品を提供することにある。
【0005】
【課題を解決するための手段】
このような目的を果たすために、本発明においては、血糖または血圧の上昇を抑制するための機能性食品を、ミカン科、ミカン属の一種で、フィリピン、中国南部の原産で、東南アジアで広く栽培されるキンカン類とミカン類の雑種からなる矮性柑橘類の全果(果皮を含む果実)の搾汁液を含有することを特徴とするものとした。
【0006】
【発明の実施の形態】
以下に本発明について詳細に説明する。
【0007】
本発明による全果、すなわち果皮を含む果実からの搾汁液を含有する機能性食品は、インスリン依存性糖尿病、およびインスリン非依存性糖尿病からなる群から選択される血糖上昇を伴う疾患などの予防、改善、或いは治療に用いることができる。また本発明による全果の搾汁液を含有した機能性食品は、本態性高血圧症並びに腎性高血圧症などの二次高血圧症、および境界型高血圧症からなる群から選択される血圧上昇を伴う疾患の予防、改善、或いは治療にも有効である。
【0008】
以下、本発明の具体的な実施例について説明する。
【0009】
本発明の機能性食品は、Calamondin(国際品種名)、四季桔(しききつ/日本名)、唐金柑(とうきつかん/日本名)、Kalamansi(フィリピン名)、四季橘(中国名)と呼ばれ、学名が、Citrus microcarpa Bunge、C. mitis Blanco、C. medica var. limetta F.-VIII、C. medurensis Lour、Pseudofortunella madurensis (Louer.) Tsengであるこれらの群から選択される柑橘類(フィリピンでは一般にカラマンシーと呼ばれ、中国南部原産で、東南アジアで広く栽培されるキンカン類とミカン類の雑種と考えられている矮性柑橘類)の全果、すなわち果皮を含む果実から搾汁した果汁に基づくものである。
【0010】
上記矮性柑橘類の全果を圧搾、または遠心分離することにより、搾汁果汁が容易に得られる。この搾汁果汁の原液、あるいは濃縮処理した液は、何ら加工しないそのままの原液でも血糖または血圧上昇の抑制作用を示す。従って、例えば1〜20%の希釈液を飲料として用いることが、日常的に容易に摂取可能であり、しかも摂取量を容易に把握可能である点に鑑み、最良と言える。
【0011】
また本発明の全果の搾汁液は、その濃縮果汁を噴霧乾燥若しくは凍結乾燥することにより、粉末あるいは固形食品を得ることができるので、これを水溶して飲用したり、菓子類やパン類など他の食品に添加したりするなど、種々の態様で容易に摂取することができる。
【0012】
次に本発明による矮性柑橘類(カラマンシー)の全果からの搾汁液を含有した水溶液の血糖上昇抑制効果の検証結果について説明する。
【0013】
8週齢、雄性の自然発症高血糖(KKA)マウスに対し、予備飼育期間中は固形飼料を与えつつ血糖測定および状態観察を行い、満腹時および空腹時の血糖の平均値がほぼ一定となるように6匹ずつ2群に群分けした。そして各群の一方に対して蒸留水を、他方に対して被験物質としてカラマンシーからの搾汁液を含有した水溶液を、それぞれ1日1回28日間連続的に強制経口投与し、投与期間中の血糖値の変動を、投与開始時、14日目、21日目、28日目に、測定日の午前10時に満腹時血糖値を、18時間絶食後の翌日の午前10時に空腹時血糖値を、それぞれ眼窩静脈叢から採血して測定した。
【0014】
なお、被験物質は200mg/kg相当量とした。試験結果は平均値±標準偏差で表し、有意差検定はstudent’s−tを用いた。
【0015】
その結果、図1及び図2に示す通り、蒸留水のみを与えた、つまり被験物質を与えなかった陽性対照群の血糖値は、試験開始時の満腹時が366mg/dl、空腹時が137mg/dlであったのに対し、28日後には、満腹時が436mg/dl、空腹時が140mg/dlと糖尿病血糖値を呈し、しかも上昇傾向にあった。
【0016】
これに対し、被験物質を投与した群は、満腹時血糖値は投与後21日までに陽性対照群に対して有意な血糖上昇抑制効果を示し(311mg/dl)、空腹時血糖値は投与後14日までに陽性対照群に対して有意な血糖上昇抑制効果を示し(126mg/dl)、その後も顕著に血糖上昇が抑制された。
【0017】
以上により、カラマンシーからの搾汁液を含有した水溶液には、自然発症高血糖(KKA)マウスに対する血糖上昇抑制効果のあることが実証された。
【0018】
次に本発明による矮性柑橘類(カラマンシー)の全果からの搾汁液を含有した水溶液の血圧上昇抑制効果の検証結果についても説明する。
【0019】
8週齢、雄性の自然発症高血圧(SHRSP)ラットに対し、予備飼育期間中は固形飼料を与えつつ血圧測定および状態観察を行い、収縮期血圧の平均値がほぼ一定となるように6匹ずつ2群に群分けした。そして各群の一方に対して蒸留水を、他方に対して被験物質としてカラマンシーからの搾汁液を含有した水溶液を、それぞれ1日1回28日間連続的に強制経口投与し、投与期間中の血圧の変動を、投与開始時、14日目、21日目、28日目に、tail cuff法を用いて測定した。なお、被験物質は200mg/kg相当量とし、ラットは38±1°Cに保温したホルダーにて保定した。試験結果は平均値±標準偏差で表し、有意差検定はstudent's-tを用いた。
【0020】
その結果、図3に示す通り、蒸留水のみを与えた、つまり被験物質を与えなかった陽性対照群の最高血圧値は、試験開始時の197mmHgから、28日後には229mmHgと高血圧症を呈し、しかも上昇傾向にあったのに対し、被験物質を投与した群は、投与後21日までに陽性対照群に対して有意な血圧上昇抑制効果を示し(208mmHg)、その後も血圧上昇が抑制された。
【0021】
以上により、被験物質のカラマンシーからの搾汁液を含有した水溶液には、自然発症高血圧(SHRSP)ラットに対する血圧上昇抑制効果のあることが実証された。
【0022】
【発明の効果】
以上詳述した通り、カラマンシーからの搾汁液を含有する本発明の機能性食品によれば、血糖の上昇を抑制する作用が得られることはもとより、血圧の上昇を抑制する作用をも得られる。従って、本発明により、糖尿病に関連する疾患の進行を副作用を伴わずに抑制する上に大きな効果が得られると共に、高血圧症に関連する疾患の進行を副作用を伴わずに抑制する上にも効果的である。
【図面の簡単な説明】
【図1】満腹時の血糖値変動グラフ
【図2】空腹時の血糖値変動グラフ
【図3】血圧値変動グラフ
[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a functional food for suppressing an increase in blood sugar or blood pressure.
[0002]
[Prior art]
Today, lifestyle-related diseases such as diabetes and hypertension are spreading mainly in developed countries in Europe and the United States, and Japan is no exception, and the rapid increase in lifestyle-related diseases associated with the westernization of the food environment has become apparent. As a result, the number of cases where malignant tumors and circulatory disorders of the brain and heart cause death is increasing in recent years.
[0003]
[Problems to be solved by the invention]
However, conventional medical drugs with high therapeutic effects for diabetes and hypertension are generally not suitable for long-term use due to the strong side effects and the problem of multiple toxicity due to multiple doses. .
[0004]
The present invention has been devised to solve such conventional problems, and its main purpose is to safely suppress the progression of diabetes or hypertension, which is the core of lifestyle-related diseases. To provide functional food.
[0005]
[Means for Solving the Problems]
In order to achieve such an object, in the present invention, a functional food for suppressing an increase in blood sugar or blood pressure is a kind of Citrusaceae and Citrus genus, native to the Philippines and southern China, and widely cultivated in Southeast Asia. The squeezed liquid of the whole fruit (fruit including a skin) of the dwarf citrus fruit which consists of the hybrid of the kumquat and the mandarin orange which are made to contain is characterized by the above-mentioned.
[0006]
DETAILED DESCRIPTION OF THE INVENTION
The present invention is described in detail below.
[0007]
The functional food containing squeezed juice from the whole fruit according to the present invention, that is, the fruit including the skin, is used for prevention of diseases associated with elevated blood sugar selected from the group consisting of insulin-dependent diabetes and non-insulin-dependent diabetes , Improvement, or treatment. The functional food containing the whole fruit juice according to the present invention is accompanied by an increase in blood pressure selected from the group consisting of essential hypertension and secondary hypertension such as renal hypertension, and borderline hypertension. It is also effective in preventing, improving, or treating diseases.
[0008]
Hereinafter, specific examples of the present invention will be described.
[0009]
The functional foods of the present invention are called Calamondin (international variety name), Shikikan (Shikitsu / Japanese name), Tangkinkan (Japanese name), Kalamansi (Philippine name), Shiki Tachibana (Chinese name). , scientific name is selected Citrus microcarpa Bunge, C. mitis Blanco , C. m ed ica var. limetta F.-V III, C. medurensis Lour, from Pseudofortunella madure ns is (louer.) these groups are Tseng Juice extracted from the whole fruit of citrus fruits (generally called calamancy in the Philippines, native to southern China and widely regarded as a hybrid of kumquats and citrus fruits widely grown in Southeast Asia) It is based on.
[0010]
By squeezing or centrifuging the whole fruit of the fertile citrus fruits, the juice juice can be easily obtained. Even if this undiluted undiluted solution is an undiluted undiluted solution, the undiluted undiluted juice or concentrated solution exhibits an effect of suppressing blood sugar or blood pressure increase. Therefore, for example, it is best to use 1 to 20% of the diluted solution as a drink in view of the fact that it can be easily ingested on a daily basis and the intake amount can be easily grasped.
[0011]
Further, the juice of whole fruit of the present invention can be obtained by spray-drying or freeze-drying the concentrated fruit juice to obtain a powder or a solid food. It can be easily ingested in various forms, such as being added to other foods.
[0012]
Then the verification results of the blood glucose increase inhibitory effect of the aqueous solution containing the pressed juice from whole-fruit dwarf citrus according to the invention (calamondin) will be described.
[0013]
Eight-week-old male spontaneously hyperglycemic (KKA y ) mice were subjected to blood glucose measurement and state observation while feeding solid chow during the pre-feeding period, and the average value of blood sugar at full and fasting was almost constant. 6 animals were divided into 2 groups. And each of the groups was distilled water for one day and an aqueous solution containing squeezed liquid from Calamancy as a test substance for the other, once a day for 28 days continuously, Changes in blood glucose levels were measured at the start of administration, on the 14th, 21st, and 28th days, at 10 am on the day of measurement, at 10 am, on the day of fasting, and at 10 am on the next day after fasting for 18 hours. The blood was collected from the orbital venous plexus and measured.
[0014]
The test substance was used in an amount equivalent to 200 mg / kg. The test results were expressed as mean values ± standard deviation, and student's-t was used for the significance test.
[0015]
As a result, as shown in FIGS. 1 and 2, the blood glucose level of the positive control group to which only distilled water was given, that is, the test substance was not given, was 366 mg / dl at the start of the test, 137 mg / dl at the fasting time. On the other hand, after 28 days, the diabetic blood glucose level was 436 mg / dl at the time of fullness and 140 mg / dl at the time of fasting, and the blood glucose level was on the rise.
[0016]
On the other hand, in the group administered with the test substance, the blood glucose level in the satiety shows a significant blood glucose rise inhibitory effect (311 mg / dl) with respect to the positive control group by 21 days after administration, and the blood glucose level in the fasting state is after the administration. By 14 days, a significant blood glucose elevation inhibitory effect was exhibited with respect to the positive control group (126 mg / dl), and thereafter the blood glucose elevation was significantly suppressed.
[0017]
Thus, the aqueous solution containing pressed juice from calamondin was demonstrated that a blood glucose elevation inhibitory effects on spontaneous hyperglycemia (KKA y) mice.
[0018]
Next, the verification result of the blood pressure increase inhibitory effect of the aqueous solution containing the squeezed liquid from the whole fruit of the fertile citrus fruits (calamancy) according to the present invention will also be described.
[0019]
For 8 weeks old, male spontaneously hypertensive (SHRSP) rats, blood pressure measurement and state observation were performed while feeding solid chow during the pre-feeding period, and 6 rats each so that the average value of systolic blood pressure was almost constant. Divided into 2 groups. And each of the groups was distilled water for one day and an aqueous solution containing squeezed liquid from Calamancy as a test substance for the other, once a day for 28 days continuously, The change in blood pressure was measured using the tail cuff method at the start of administration, on days 14, 21, and 28. The test substance was equivalent to 200 mg / kg, and the rats were kept in a holder kept at 38 ± 1 ° C. The test results were expressed as mean values ± standard deviation, and student's-t was used for the significance test.
[0020]
As a result, as shown in FIG. 3, the maximum blood pressure value of the positive control group that received only distilled water, that is, the test substance was not increased from 197 mmHg at the start of the test to 229 mmHg after 28 days and exhibited hypertension, In contrast, the group administered with the test substance showed a significant blood pressure increase inhibitory effect with respect to the positive control group by the 21st day after administration (208 mmHg), and the blood pressure increase was suppressed thereafter. .
[0021]
Based on the above, it was demonstrated that an aqueous solution containing the juice of test substance from calamancy has an effect of suppressing blood pressure elevation in spontaneously hypertensive (SHRSP) rats.
[0022]
【The invention's effect】
As described in detail above, according to the functional food of the present invention containing the juice from Karamanshi, it is possible to obtain an action of suppressing an increase in blood pressure as well as an action of suppressing an increase in blood sugar. . Therefore, according to the present invention, a great effect is obtained in suppressing the progression of the disease related to diabetes without causing side effects, and also effective in suppressing the progression of the disease related to hypertension without causing side effects. Is.
[Brief description of the drawings]
[Fig. 1] Blood glucose level fluctuation graph at full stomach [Fig. 2] Blood glucose level fluctuation graph at fasting [Fig. 3] Blood pressure level fluctuation graph

Claims (4)

ミカン科、ミカン属の一種で、フィリピン、中国南部の原産で、東南アジアで広く栽培されるキンカン類とミカン類の雑種からなる矮性柑橘類の全果(果皮を含む果実)の搾汁液を含有することを特徴とする血糖上昇を抑制するための機能性食品。It is a kind of Citrus family and Citrus genus. It contains squeezed juice of all fruit (including fruit skin) of fertile citrus fruits, which are native to the Philippines and southern China and are a mixture of kumquats and citrus fruits widely cultivated in Southeast Asia. A functional food for suppressing an increase in blood sugar. 前記柑橘類は、Calamondin(国際品種名)、四季桔(しききつ/日本名)、唐金柑(とうきつかん/日本名)、Kalamansi(フィリピン名)、四季橘(中国名)と呼ばれ、学名が、Citrus microcarpa Bunge、C. mitis Blanco、C. medica var. limetta F.-VIII、C. medurensis Lour、Pseudofortunellamadurensis (Louer.) Tsengであるこれらの群から選択されることを特徴とする請求項1に記載の血糖上昇を抑制するための機能性食品。The citrus fruits are called Calamondin (international varieties), Shikikan (Shikitsu / Japanese name), Tangkinkan (Tokitsukan / Japanese name), Kalamansi (Philippine name), Shiki Tachibana (Chinese name). Citrus microcarpa Bunge, C. mitis Bla nc o, C. medica var. limetta F.-V III, C. medurensis Lour, Pseudofortunellamadurensis (louer.) is Tseng claims, characterized in that it is selected from these groups 2. A functional food for suppressing an increase in blood glucose according to 1. ミカン科、ミカン属の一種で、フィリピン、中国南部の原産で、東南アジアで広く栽培されるキンカン類とミカン類の雑種からなる矮性柑橘類の全果(果皮を含む果実)の搾汁液を含有することを特徴とする血圧上昇を抑制するための機能性食品。It is a kind of Citrus family and Citrus genus. It contains squeezed juice of all fruit (including fruit skin) of fertile citrus fruits, which are native to the Philippines and southern China and are a mixture of kumquats and citrus fruits widely cultivated in Southeast Asia. A functional food for suppressing an increase in blood pressure. 前記柑橘類は、Calamondin(国際品種名)、四季桔(しききつ/日本名)、唐金柑(とうきつかん/日本名)、Kalamansi(フィリピン名)、四季橘(中国名)と呼ばれ、学名が、Citrus microcarpa Bunge、C. mitis Blanco、C. medica var. limetta F.-VIII、C. medurensis Lour、Pseudofortunellamadurensis (Louer.) Tsengであるこれらの群から選択されることを特徴とする請求項3に記載の血圧上昇を抑制するための機能性食品。The citrus fruits are called Calamondin (international varieties), Shikikan (Shikitsu / Japanese name), Tangkinkan (Tokitsukan / Japanese name), Kalamansi (Philippine name), Shiki Tachibana (Chinese name). Citrus microcarpa Bunge, C. mitis Bla nc o, C. medica var. limetta F.-V III, C. medurensis Lour, Pseudofortunellamadurensis (louer.) is Tseng claims, characterized in that it is selected from these groups 3. A functional food for suppressing an increase in blood pressure according to 3.
JP2002000077A 2002-01-04 2002-01-04 Functional food for suppressing blood sugar or blood pressure rise Expired - Fee Related JP3610340B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002000077A JP3610340B2 (en) 2002-01-04 2002-01-04 Functional food for suppressing blood sugar or blood pressure rise

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002000077A JP3610340B2 (en) 2002-01-04 2002-01-04 Functional food for suppressing blood sugar or blood pressure rise

Publications (2)

Publication Number Publication Date
JP2003199527A JP2003199527A (en) 2003-07-15
JP3610340B2 true JP3610340B2 (en) 2005-01-12

Family

ID=27640585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002000077A Expired - Fee Related JP3610340B2 (en) 2002-01-04 2002-01-04 Functional food for suppressing blood sugar or blood pressure rise

Country Status (1)

Country Link
JP (1) JP3610340B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5327732B2 (en) * 2007-08-31 2013-10-30 広島県 α-Glucosidase inhibitor and method for producing the same
FR2943535B1 (en) 2009-03-31 2011-08-12 Lvmh Rech NEW USE OF A PLANT EXTRACT OBTAINED FROM AT LEAST ONE PLANT BELONGING TO THE GENUS CITRUS, OR A HYBRID FROM THE CROSSING OF VEGETABLE SPECIES OF WHICH AT LEAST ONE APPEARS TO THE GENUS CITRUS.
KR101986656B1 (en) * 2017-02-10 2019-06-07 최재원 Manufacturing method of fermented soybean paste having Citrus Microcarpa Bunge
CN112107628B (en) * 2020-10-28 2021-11-23 江西中医药大学 Kumquat essential oil and preparation method and application thereof

Also Published As

Publication number Publication date
JP2003199527A (en) 2003-07-15

Similar Documents

Publication Publication Date Title
CN104431064B (en) A kind of blood-sugar reducing tea and preparation method thereof
CN104054769A (en) Functional bread for treating cardiovascular disease and making method of functional bread
CN102526479B (en) Health-care medicine formula with functions of enhancing immunity and lowering blood sugar
CN112546167A (en) Traditional Chinese medicine composition with spleen invigorating and dampness removing functions and preparation method and application thereof
JP3610340B2 (en) Functional food for suppressing blood sugar or blood pressure rise
CN108570116A (en) Yellowish green frizzle mushroom polysaccharide and preparation method and the medical application in preventing diabetes
KR100831621B1 (en) Food composition for lowering blood sugar
CN117138012B (en) A Chinese medicine composition for treating chest pain and heartache, and its preparation method and application
KR20010074477A (en) Hypoglycemic agents
US20020197338A1 (en) Botanical composition and methods for the treatment or prevention of obesity
CN106074671A (en) U.S. rattan fruit leaf extract application in preparing hypoglycemic drug
JP3677007B2 (en) Anti-diabetic ingredient-containing food composition
CN108837082A (en) A kind of Traditional Chinese medicine compound composition of auxiliary hyperglycemic and preparation method thereof
CN108159296A (en) A kind of complex polysaccharide and preparation method and application with clearing heat and nourishing yin, function of blood sugar reduction
JP3476835B2 (en) Yacon / oolong blended food
CN107349192A (en) Application of Poria Cortex Extract, Pachynic Acid A, and Pachymic Acid B in Regulating Blood Sugar
JP2002154978A (en) Hypoglycemic substance and its functional food
AU2021104385A4 (en) Biscuit for early prevention and treatment of type 2 diabetes, and preparation method thereof
KR100573590B1 (en) Herbal composition for the treatment and suppression of obesity
CN101229274B (en) Pharmaceutical composition for preventing or treating impotence induced by hyperlipidemia and/or hypertension
Waheed et al. Clinical investigation of hypoglycemic effect of Eugenia jambolana in type-ii (niddm) Diabetes mellitus
CN100560085C (en) A kind of Chinese herbal medicine and uses thereof
CN108185423A (en) A kind of health food that can improve immunity
JPS61143324A (en) Food for improving blood pressure and blood sugar level
JPH0827014A (en) Hypoglycemic agent containing crow plant fruit extract

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040413

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040706

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040830

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040830

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20041005

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041018

R150 Certificate of patent or registration of utility model

Ref document number: 3610340

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081022

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081022

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091022

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091022

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101022

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111022

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121022

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121022

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131022

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees